About Cellarity
Cellarity is a company based in Cambridge (United States) founded in 2015 by Avak Kahvejian. Cellarity has raised $294 million across 3 funding rounds from investors including BlackRock, Flagship Pioneering and Kyowa Kirin. The company has 117 employees as of December 31, 2022. Cellarity offers products and services including Cellarity Platform and Pipeline. Cellarity operates in a competitive market with competitors including Asimov, Metaphore, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
- Headquarter Cambridge, United States
- Employees 117 as on 31 Dec, 2022
- Founders Avak Kahvejian
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$294 M (USD)
in 3 rounds
-
Latest Funding Round
$121 M (USD), Series C
Oct 04, 2022
-
Investors
BlackRock
& 6 more
-
Employee Count
117
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellarity
Cellarity offers a comprehensive portfolio of products and services, including Cellarity Platform and Pipeline.
Platform for analyzing omics data to design medicines.
System for developing medicines against cellular dysfunction.
People of Cellarity
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Cellarity
Cellarity has successfully raised a total of $294M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $121 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $121.0M
-
First Round
First Round
(10 Dec 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series C - Cellarity | Valuation |
investors |
|
| Feb, 2021 | Amount | Series B - Cellarity | Valuation | BlackRock , The Baupost Group | |
| Dec, 2019 | Amount | Series A - Cellarity | Valuation |
investors |
|
Investors in Cellarity
Cellarity has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include BlackRock, Flagship Pioneering and Kyowa Kirin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location | |
|
Infrastructure and venture capital firm focused on renewable energy, technology, and life science sectors
|
Founded Year | Domain | Location | |
|
Developer of biologics for multiple diseases and disorders
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellarity
Financial Statements - Cellarity
Cellarity Comparisons
Competitors of Cellarity
Cellarity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Metaphore, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| domain | founded_year | HQ Location |
Provider of machine language and computational platform for drug discovery
|
|
| domain | founded_year | HQ Location |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| domain | founded_year | HQ Location |
Digital technology for biomedicinal molecule development in research is utilized.
|
|
| domain | founded_year | HQ Location |
Provider of software solutions for molecular diagnostics and discovery
|
Latest news on Cellarity
Frequently Asked Questions about Cellarity
Cellarity was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Cellarity is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Avak Kahvejian is the current CEO of Cellarity. They have also founded this company.
Cellarity is a funded company, having raised a total of $294M across 3 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Dec 10, 2019.
As of Dec 31, 2022, the latest employee count at Cellarity is 117.
Cellarity was founded in 2015 in Cambridge, United States, within the biotechnology sector. Single-cell technologies and machine learning are integrated into a platform to digitize and quantify cellular behaviors. Medicines are designed through this approach for applications in hematology, immuno-oncology, metabolism, and respiratory diseases. Operations focus on drug development to address these therapeutic areas.
Cellarity offers Cellarity Platform and Pipeline.
Cellarity has 7 investors. Key investors include BlackRock, Flagship Pioneering, Kyowa Kirin, Hanwha Impact, and The Baupost Group.